Literature DB >> 24299144

Same-day assessment and management of urgent (2-week wait) colorectal referrals: an analysis of the outcome of 1606 patients attending an endoscopy unit-based colorectal clinic.

T J Royle1, H J M Ferguson, T W C Mak, J A Simpson, V Thumbe, S Bhalerao.   

Abstract

AIM: The Rapid Access Diagnosis and Remedy (RADAR) clinic combines 2-week wait (TWW) specialist consultation with 'straight-to-test' flexible sigmoidoscopy (FS) for left-sided 'red-flag' TWW criteria (excluding right-sided mass or iron-deficiency anaemia). The study aims were to determine the effectiveness of RADAR in differentiating colorectal cancer from benign disease and to evaluate the need for whole colonic investigation (WCI) following FS, in symptomatic patients.
METHOD: Prospectively collated data of all RADAR patients from November 2005 to November 2009 were analysed, excluding patients referred internally for a FS. The local histology database was later interrogated to detect any missed cancers.
RESULTS: Of 1690 patients (729 men; median (range) age: 68 (18-96) years) assessed in RADAR, 84 were excluded. Colorectal cancer (CRC) was diagnosed in 117 (7.3%). Eighty-seven cancers were diagnosed on the day of attendance and a further 13 within a week (88.9% overall). Two patients after a cancer-free FS were found to have a right-sided CRC on WCI (0.24%) and one synchronous cancer was found. No patient with a cancer-free FS having a WCI was subsequently found to have CRC at a median of 35 (12-58) months.
CONCLUSION: Flexible sigmoidoscopy, in the context of an endoscopy unit TWW clinic, allows same-day diagnosis of most patients referred with left-sided symptoms, and immediate reassurance and treatment of most benign diagnoses. For these patients, the use of routine WCI following a cancer-free FS does not appear to be beneficial. Adopting this system would significantly reduce the number of barium enemas and colonoscopies currently performed. Colorectal Disease
© 2013 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Keywords:  Sigmoidoscopy; ambulatory care; colorectal neoplasms; diagnosis; referral and consultation

Mesh:

Substances:

Year:  2014        PMID: 24299144     DOI: 10.1111/codi.12508

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  5 in total

1.  Safe investigation of isolated change in bowel habit with a flexible sigmoidoscopy? A systematic review and meta-analysis.

Authors:  Pjj Herrod; H Boyd-Carson; B Doleman; Jem Blackwell; Ejo Hardy; F Harper; J N Lund
Journal:  Ann R Coll Surg Engl       Date:  2019-03-11       Impact factor: 1.891

2.  Urinary Volatile Organic Compound Testing in Fast-Track Patients with Suspected Colorectal Cancer.

Authors:  Caroline E Boulind; Oliver Gould; Ben de Lacy Costello; Joanna Allison; Paul White; Paul Ewings; Alfian N Wicaksono; Nathan J Curtis; Anne Pullyblank; David Jayne; James A Covington; Norman Ratcliffe; Claire Turner; Nader K Francis
Journal:  Cancers (Basel)       Date:  2022-04-24       Impact factor: 6.575

3.  Prevalence of pelvic floor symptoms in female patients attending the two-week wait clinic with suspected colorectal cancer.

Authors:  J Bennett; A Greenwood; P Durdey; D Glancy
Journal:  Ann R Coll Surg Engl       Date:  2016-04-15       Impact factor: 1.891

4.  How do the characteristics of breast cancer diagnostic assessment programmes influence service delivery: A mixed methods study.

Authors:  A R Gagliardi; G Honein-AbouHaidar; T Stuart-McEwan; J Smylie; A Arnaout; J Seely; F C Wright; M J Dobrow; M C Brouwers; K Bukhanov; D R McCready
Journal:  Eur J Cancer Care (Engl)       Date:  2017-06-21       Impact factor: 2.520

5.  Whole-colon investigation vs. flexible sigmoidoscopy for suspected colorectal cancer based on presenting symptoms and signs: a multicentre cohort study.

Authors:  Amanda J Cross; Kate Wooldrage; Emma C Robbins; Kevin Pack; Jeremy P Brown; William Hamilton; Michael R Thompson; Karen G Flashman; Steve Halligan; Siwan Thomas-Gibson; Margaret Vance; Brian P Saunders; Wendy Atkin
Journal:  Br J Cancer       Date:  2018-12-19       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.